| Metric | Value (₹ Cr) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 13.11 | 4.8% | 8.9% |
| Total Income | 13.24 | 4.7% | 20.5% |
| Expenditure | 11.73 | 5.0% | 8.7% |
| PBT | 1.51 | 2.0% | 74.3% |
| Net Profit | 0.87 | 35.0% | 83.4% |
| OPM | 41.28% | 2.59pp | 67.20pp |
| NPM | 6.56% | 4.01pp | 24.85pp |
| EPS | 0.45 | 39.2% | 87.2% |
Vivo Bio Tech Ltd Announces Q2 and H1 FY2025 Financial Results with 150.98% YoY Profit Before Tax Growth
14 Nov 2025 · 14 Nov 2025, 04:54 pm
Summary
Vivo Bio Tech Ltd has announced its Q2 and H1 FY2025 financial results. The company has reported a significant YoY profit before tax growth of 150.98%. The revenue from operations for the quarter ended on 30.09.2025 was 1,301.6, a YoY increase of 7.22%. The net profit after tax for the quarter was 757.0. The company's earnings per equity share for the quarter were 3.62 for basic and 1.14 for diluted.
Key Highlights
- 1
Q2 and H1 FY2025 financial results announced
- 2
150.98% YoY profit before tax growth
- 3
Revenue from operations for Q3 2025: 1,301.6
- 4
YoY increase in revenue from operations: 7.22%
- 5
Net profit after tax for Q3 2025: 757.0
- 6
Earnings per equity share for Q3 2025: 3.62 (basic), 1.14 (diluted)
Management Comments
Kalyan Ram Mangipudi
Please refer to the financial document for the detailed comments from the management.
Informational and educational content only. Not investment advice.